Sign In
Buy IDXX
$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Monday, 04'th May 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Here's How IDEXX Laboratories Is Placed Ahead of Q1 Earnings
10:11am, Friday, 01'st May 2026
IDXX heads into Q1 earnings with strong growth forecasts, steady estimate beats, and momentum in diagnostics and recurring revenue streams.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Thursday, 30'th Apr 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Comerica Bank Sells 9,639 Shares of IDEXX Laboratories, Inc. $IDXX
02:41pm, Wednesday, 29'th Apr 2026
Comerica Bank lessened its holdings in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 35.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)
IDXX DCF Analysis: Intrinsic Value $398 vs Price $568
07:31am, Wednesday, 29'th Apr 2026
On April 29, 2026, we take a closer look at the DCF analysis for IDEXX Laboratories Inc (IDXX). The company has experienced a price performance of -0.1% over th
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Tuesday, 28'th Apr 2026
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stryker to Report Q1 Earnings: What's in Store for the Stock?
09:50am, Tuesday, 28'th Apr 2026
SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
A $5 million gift from the storied entrepreneur, activist, and impact investor will advance the University of New England's work at the intersection of environmental and human health while boosting Ma
IDEXX Laboratories, Inc. $IDXX Shares Sold by AEGON ASSET MANAGEMENT UK Plc
03:09am, Sunday, 26'th Apr 2026
AEGON ASSET MANAGEMENT UK Plc reduced its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.6% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The
Is IDXX Overvalued? DCF Says Worth $398
07:04am, Thursday, 23'rd Apr 2026
On April 23, 2026, we delve into the DCF analysis for IDEXX Laboratories Inc (IDXX), a company currently priced at $578.35. Over the past year, IDXX has demonst
IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison
11:27am, Wednesday, 22'nd Apr 2026
Idexx Laboratories, Inc. and Zoetis Inc. are dominant players in animal health, but IDXX outperforms due to superior capital efficiency and recurring revenue flywheel. ZTS trades at a much lower valua
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 16'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Assetmark Inc. Purchases 1,518 Shares of IDEXX Laboratories, Inc. $IDXX
03:17am, Wednesday, 15'th Apr 2026
Assetmark Inc. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Ex
Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now?
02:06pm, Tuesday, 14'th Apr 2026
IDEXX Laboratories, Inc. IDXX is expanding its global commercial capabilities to support continued growth in its CAG Diagnostics recurring revenue stream. The company's software ecosystem remains a ke
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 14'th Apr 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
